Bard Venovo Stent

Bard Venovo™ Venous Stent System
The Bard Venovo™ Venous Stent System is a self-expanding nitinol venous stent engineered to treat symptomatic iliofemoral venous obstructions, including post-thrombotic and non-thrombotic lesions. Designed with a unique balance of radial strength, flexibility, and compression resistance, the Venovo stent helps clinicians provide effective endovascular therapy for patients with deep venous disease.

Key Features
Dedicated Venous Design: Specifically developed for the iliofemoral veins, including common iliac and femoral venous segments.
Self-Expanding Nitinol Construction: High-performance nitinol material offers excellent radial force and flexibility for durable vessel support.
Wide Size Range: Available in multiple diameters (up to 20 mm) and lengths (up to 160 mm) to accommodate various venous anatomies and lesion lengths.
Tri-Axial Delivery System: Designed for precise placement and improved deployment control during endovascular procedures.
Flared Ends: Engineered to enhance wall apposition and reduce the risk of stent migration.

Clinical Benefits
Effective Venous Revascularization: Helps restore blood flow and relieve symptoms related to iliofemoral vein obstruction.
Supported by Clinical Evidence: The Venovo stent has demonstrated consistent primary patency and technical success in clinical studies, with low fracture and migration rates reported.
Improved Quality of Life: Patients treated with the Venovo stent system have shown significant symptom improvement and durable outcomes over time.

Ideal Use
The Bard Venovo™ Venous Stent System is indicated for endovascular treatment of symptomatic iliofemoral venous outflow obstruction, including chronic deep vein thrombosis (DVT) and May–Thurner syndrome cases. Consultation with a qualified vascular specialist is recommended for appropriate patient selection and procedural planning.